Influenza A: New Therapeutic Targets for a Deadly Disease
Arch Bronconeumol (Engl Ed). 2019 Jun;55(6):295-296.
doi: 10.1016/j.arbres.2018.09.020.
Epub 2018 Nov 5.
[Article in
English,
Spanish]
Affiliations
- 1 Hospital Universitario de Getafe, Madrid, Spain.
- 2 CIC biomaGUNE, Donostia-San Sebastian, Spain; CIBER de Enfermedades Respiratorias, Spain.
- 3 Multidisciplinary Intensive Care Research Organization (MICRO), Department of Intensive Care Medicine, St James's Hospital, Dublin, Ireland.
- 4 Hospital Universitario de Getafe, Madrid, Spain; CIBER de Enfermedades Respiratorias, Spain; Universidad Europea, Madrid, Spain. Electronic address: jose_angel_lorente@hotmail.com.
No abstract available
MeSH terms
-
Animals
-
Antiviral Agents / pharmacology
-
Antiviral Agents / therapeutic use*
-
Cell Death
-
Clinical Trials as Topic
-
Drug Delivery Systems
-
Drug Evaluation, Preclinical
-
Host-Pathogen Interactions / drug effects
-
Humans
-
Influenza A virus / drug effects*
-
Influenza A virus / genetics
-
Influenza A virus / metabolism
-
Influenza, Human / drug therapy*
-
Mice
-
Orthomyxoviridae Infections / drug therapy
-
Receptors, Virus / drug effects
-
Viral Proteins / antagonists & inhibitors
Substances
-
Antiviral Agents
-
Receptors, Virus
-
Viral Proteins